Foseco to sell 1.77% stake in FCIL for ₹1,347.5 crore
Foseco India Limited's Board approved the sale of up to 99,081 equity shares, representing a 1.77% stake in subsidiary Foseco Crucible (India) Limited, to comply with minimum public shareholding regulations. The transaction, expected to fetch around ₹1,347.5 crore, will be executed via open market or other SEBI-permitted methods between May 18, 2026, and March 31, 2027.

*this image is generated using AI for illustrative purposes only.
Foseco India Limited has announced that its Board of Directors approved a proposal to divest a portion of its shareholding in its subsidiary, Foseco Crucible (India) Limited (FCIL). The decision, taken during a meeting on May 12, 2026, aims to facilitate compliance with the minimum public shareholding requirements mandated by the Securities Contracts (Regulation) Rules, 1957 (SCRR) and Regulation 38 of the SEBI Listing Regulations.
The company plans to sell up to 99,081 fully paid-up equity shares of FCIL, each with a face value of ₹5. This quantity constitutes 1.77% of the total voting share capital of the subsidiary. The divestment will be executed in one or more tranches, utilizing methods permitted by SEBI, including the open market mechanism.
Financial Impact and Valuation
FCIL contributes significantly to the consolidated financials of the parent entity. During the last financial year, the subsidiary reported a turnover of ₹3,940.20 Lakh, accounting for 6.1% of the company's consolidated turnover. Additionally, FCIL’s net worth stood at ₹14,091.74 Lakh, representing 13.6% of the consolidated net worth.
The sale is anticipated to generate substantial proceeds for the company. Based on the disposal of the entire proposed tranche of 99,081 shares, the expected consideration is approximately ₹1,347.5 crore. The transaction window is scheduled to commence on May 18, 2026, and will conclude on March 31, 2027, or upon the actual completion of the sale, whichever occurs earlier.
Transaction Details
The following table outlines the key particulars of the proposed transaction as disclosed in the regulatory filing:
| Particulars | Details |
|---|---|
| Subsidiary | Foseco Crucible (India) Limited (FCIL) |
| Shares to be sold | 99,081 fully paid-up equity shares |
| Percentage of stake | 1.77% of total voting share capital |
| Face value | ₹5 per share |
| Expected consideration | ₹1,347.5 crore (approx.) |
| Sale period | May 18, 2026 to March 31, 2027 |
| Method of sale | Open market mechanism and/or other SEBI-permitted methods |
The company confirmed that the transaction does not fall within the scope of related party transactions and will not be conducted through a slump sale or a Scheme of Arrangement. The disclosure was made to ensure transparency and adherence to regulatory obligations.
Historical Stock Returns for Foseco
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -8.51% | +4.03% | +10.64% | -8.61% | +23.48% | +268.21% |
How might the reduction in Foseco India's stake in FCIL impact the parent company's consolidated net worth and earnings per share over the next fiscal year?
Could the open market sale of FCIL shares trigger increased retail investor interest in the subsidiary, and what valuation premium or discount might FCIL trade at post-listing compliance?
Will Foseco India consider further divestment of FCIL shares beyond the minimum public shareholding threshold to unlock additional capital for reinvestment or debt reduction?


































